Virtus Investment Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Buy
+1,826
New +$1.85M 0.46% 87
2025
Q3
Sell
-1,565
Closed -$1.22M 459
2025
Q2
$1.22M Sell
1,565
-202
-11% -$157K 0.41% 132
2025
Q1
$1.46M Buy
1,767
+1,567
+784% +$1.3M 0.4% 42
2024
Q4
$154K Buy
+200
New +$166K 0.12% 221
2024
Q3
Sell
-288
Closed -$261K 363
2024
Q2
$261K Sell
288
-162
-36% -$130K 0.22% 139
2024
Q1
$350K Buy
+450
New +$320K 0.25% 114
2023
Q1
Sell
-836
Closed -$306K 315
2022
Q4
$306K Hold
836
0.2% 147
2022
Q3
$270K Buy
+836
New +$265K 0.12% 162
2018
Q1
Sell
-4,088
Closed -$345K 259
2017
Q4
$345K Sell
4,088
-97
-2% -$8.25K 0.04% 337
2017
Q3
$358K Sell
4,185
-573
-12% -$47K 0.04% 347
2017
Q2
$392K Sell
4,758
-879
-16% -$71.7K 0.04% 350
2017
Q1
$474K Buy
+5,637
New +$451K 0.04% 336
2016
Q4
Sell
-32,407
Closed -$2.6M 509
2016
Q3
$2.6M Buy
+32,407
New +$2.59M 0.17% 186

Other funds holding LLY

Virtus Investment Advisers's LLY Position: Q1 2026 in Review

Virtus Investment Advisers opened a new position in Eli Lilly (LLY) in Q1 2026: 1,826 shares worth $1.68M. The stake represents 0.46% of the portfolio and ranks #87 among its holdings. This is a return to the name: Virtus Investment Advisers previously reported a position in LLY as recently as Q2 2025.

Virtus Investment Advisers first reported a position in LLY in Q3 2016 and has held it in 13 quarters since. The position peaked at $2.6M in Q3 2016. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Virtus Investment Advisers held 1,826 shares of Eli Lilly worth $1.68M as of Q1 2026.
  • Eli Lilly was a new Virtus Investment Advisers position in Q1 2026.
  • Eli Lilly made up 0.46% of Virtus Investment Advisers's portfolio in Q1 2026, its #87 holding.
  • Virtus Investment Advisers first reported a position in Eli Lilly in Q3 2016 and has held it in 13 quarters since.
  • Virtus Investment Advisers's Eli Lilly position peaked at $2.6M in Q3 2016.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.